RNA interference of LRRK2–microarray expression analysis of a Parkinson’s disease key player

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neurogenetics

• Publication date

  2008-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10048-007-0114-0PMID 18097693
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Parkinson's disease].

  2022cited by this paper
• BMC Developmental Biology BioMed Central

  2008cited by this paper
• p53 protein, interferon-γ, and NF-κB levels are elevated in the parkinsonian brain

  2007cited by this paper
• p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.

  2007cited by this paper
• Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity.

  2007cited by this paper
• qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data

  2007cited by this paper
• Genetics of Parkinson’s disease and parkinsonism

  2007cited by this paper
• LRK-1, a C. elegans PARK8-related kinase, regulates axonal-dendritic polarity of SV proteins.

  2007cited by this paper
• MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis.

  2007cited by this paper
• LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity.

  2007cited by this paper
• Identification of potential protein interactors of Lrrk2.

  2007cited by this paper
• Gene targeting of Cdc42 and Cdc42GAP affirms the critical involvement of Cdc42 in filopodia induction, directed migration, and proliferation in primary mouse embryonic fibroblasts.

  2006cited by this paper
• The subcellular fractionation properties and function of insulin receptor substrate-1 (IRS-1) are independent of cytoskeletal integrity.

  2006cited by this paper
• Translation Repression in Human Cells by MicroRNA-Induced Gene Silencing Requires RCK/p54

  2006cited by this paper
• Genetics of Parkinson's disease and parkinsonism

  2006cited by this paper
• p53 Mediates Nontranscriptional Cell Death in Dopaminergic Cells in Response to Proteasome Inhibition*

  2006cited by this paper
• LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.

  2006cited by this paper
• LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?

  2006cited by this paper
• The Parkinson disease gene LRRK2: evolutionary and structural insights.

  2006cited by this paper
• LRRK2 in Parkinson's disease: protein domains and functional insights.

  2006influential reference
• A common LRRK2 mutation in idiopathic Parkinson's disease.

  2005cited by this paper
• Inhibitory effect of c-Myc on p53-induced apoptosis in leukemia cells. Microarray analysis reveals defective induction of p53 target genes and upregulation of chaperone genes

  2005cited by this paper
• Selection of reference genes for quantitative real-time PCR in bovine preimplantation embryos

  2005cited by this paper
• G2019S LRRK2 mutation in French and North African families with Parkinson's disease

  2005cited by this paper
• Genetics of Parkinson's disease.

  2005cited by this paper
• Genetics of Parkinson's disease

  2005cited by this paper
• LRRK2 mutations in Parkinson disease

  2005cited by this paper
• Activation of Wild Type p53 Function by Its Mortalin-binding, Cytoplasmically Localizing Carboxyl Terminus Peptides*

  2005cited by this paper
• Basic fibroblast growth factor suppresses p53 activation in the neoplastic cells of a proportion of patients with chronic lymphocytic leukaemia

  2005cited by this paper
• Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis

  2005cited by this paper
• Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration.

  2005influential reference
• Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations.

  2005cited by this paper
• A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease.

  2005cited by this paper
• Improved real-time RT-PCR method for high-throughput measurements using second derivative calculation and double correction.

  2005cited by this paper
• Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.

  2004cited by this paper
• Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.

  2004cited by this paper
• Repression of hsp90β Gene by p53 in UV Irradiation-induced Apoptosis of Jurkat Cells*

  2004cited by this paper
• Specification of actin filament function and molecular composition by tropomyosin isoforms.

  2003cited by this paper
• Human Autophagins, a Family of Cysteine Proteinases Potentially Implicated in Cell Degradation by Autophagy*

  2003cited by this paper
• A Product of the Human Gene Adjacent to parkin Is a Component of Lewy Bodies and Suppresses Pael Receptor-induced Cell Death*

  2003cited by this paper
• Killing the messenger: short RNAs that silence gene expression

  2003cited by this paper
• FGF-2 induced reorganization and disruption of actin cytoskeleton through PI 3-kinase, Rho, and Cdc42 in corneal endothelial cells.

  2003cited by this paper
• Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor.

  2002cited by this paper
• Gene expression profile in fibroblast growth factor 2-transformed endothelial cells

  2002cited by this paper
• Signaling mechanisms that regulate actin‐based motility processes in the nervous system

  2002cited by this paper
• Mixed lineage kinase ZAK utilizing MKK7 and not MKK4 to activate the c-Jun N-terminal kinase and playing a role in the cell arrest.

  2002cited by this paper
• Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR

  2002cited by this paper
• Sequential tethering of Golgins and catalysis of SNAREpin assembly by the vesicle-tethering protein p115

  2002cited by this paper
• Human Genome and Diseases:¶WD-repeat proteins: structure characteristics, biological function, and their involvement in human diseases

  2001cited by this paper
• In Vitro Selection and Characterization of Bcl-XL-binding Proteins from a Mix of Tissue-specific mRNA Display Libraries*

  2001cited by this paper
• Activation of Phosphatidylinositol-3 Kinase (PI-3K) and Extracellular Regulated Kinases (Erk1/2) Is Involved in Muscarinic Receptor-Mediated DNA Synthesis in Neural Progenitor Cells

  2001cited by this paper
• The Rab GTPase family

  2001cited by this paper
• A new mathematical model for relative quantification in real-time RT-PCR.

  2001cited by this paper
• Bone Morphogenetic Protein-2 Inhibits Serum Deprivation-induced Apoptosis of Neonatal Cardiac Myocytes through Activation of the Smad1 Pathway*

  2001cited by this paper
• p53 directs conformational change and translation initiation blockade of human fibroblast growth factor 2 mRNA

  2001cited by this paper
• Novel Dendritic Kinesin Sorting Identified by Different Process Targeting of Two Related Kinesins: KIF21A and KIF21B

  1999cited by this paper
• Effects of growth factors and basement membrane proteins on the phenotype of U-373 MG glioblastoma cells as determined by the expression of intermediate filament proteins.

  1998cited by this paper
• β-Tropomyosin Overexpression Induces Severe Cardiac Abnormalities

  1998cited by this paper
• Beta-tropomyosin overexpression induces severe cardiac abnormalities.

  1998cited by this paper
• The role of MAP4 expression in the sensitivity to paclitaxel and resistance to vinca alkaloids in p53 mutant cells

  1998cited by this paper
• Citron Rho-interacting Kinase, a Novel Tissue-specific Ser/Thr Kinase Encompassing the Rho-Rac-binding Protein Citron*

  1998cited by this paper
• Parkinson's disease. First of two parts.

  1998cited by this paper
• Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas

  1997influential reference
• Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade.

  1996cited by this paper
• Mammalian Cdc42 Is a Brefeldin A-sensitive Component of the Golgi Apparatus*

  1996cited by this paper
• The leucine-rich repeat: a versatile binding motif.

  1994cited by this paper
• Demonstration of selective protein complexes of p53 with 73 kDa heat shock cognate protein, but not with 72 kDa heat shock protein in human tumor cells.

  1993cited by this paper
• ReportThe Familial Parkinsonism Gene LRRK 2 Regulates Neurite Process Morphology

  year unknowncited by this paper

• Advanced gene therapy in Parkinson’s disease through innovations in drug delivery systems

  2025cites this paper
• Micro-and mesoscale aspects of neurodegeneration in engineered human neural networks carrying the LRRK2 G2019S mutation

  2024cites this paper
• Identification of biomarkers in Parkinson’s disease by comparative transcriptome analysis and WGCNA highlights the role of oligodendrocyte precursor cells

  2024cites this paper
• Validation of a Suitable Housekeeping Gene in Human Neuroblastoma SHSY-5Y Cell-Line Treated with Steroid Hormones Progesterone and Testosterone

  2023cites this paper
• Recent advances in novel mutation genes of Parkinson's disease

  2023cites this paper
• Identification of Targets from LRRK2 Rescue Phenotypes

  2021cites this paper
• NAPE-specific phospholipase D regulates LRRK2 association with neuronal membranes.

  2021cites this paper
• Parkinson’s Disease: Potential Actions of Lithium by Targeting the WNT/β-Catenin Pathway, Oxidative Stress, Inflammation and Glutamatergic Pathway

  2021cites this paper
• Potential role of cannabidiol in Parkinson’s disease by targeting the WNT/β-catenin pathway, oxidative stress and inflammation

  2021cites this paper
• Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulation.

  2021cites this paper
• Correction to: Parkinson’s disease-related Leucine-rich repeat kinase 2 modulates nuclear morphology and genomic stability in striatal projection neurons during aging

  2020cites this paper
• VIP Induces Changes in the F-/G-Actin Ratio of Schlemm's Canal Endothelium via LRRK2 Transcriptional Regulation

  2020cites this paper
• Baicalin Represses C/EBPβ via Its Antioxidative Effect in Parkinson's Disease

  2020cites this paper
• Parkinson’s disease-related Leucine-rich repeat kinase 2 modulates nuclear morphology and genomic stability in striatal projection neurons during aging

  2020cites this paper
• Guilt-by-Association – Functional Insights Gained From Studying the LRRK2 Interactome

  2020cites this paper
• Structural and functional alterations associated with the LRRK2 G2019S mutation revealed in structured human neural networks

  2020cites this paper
• LRRK2-mediated phosphorylation of HDAC6 regulates HDAC6-cytoplasmic dynein interaction and aggresome formation

  2019cites this paper
• Leucine-rich repeat kinase 2 aggravates secondary brain injury induced by intracerebral hemorrhage in rats by regulating the P38 MAPK/Drosha pathway.

  2018cites this paper
• Disruption of LRRK2 in Zebrafish leads to hyperactivity and weakened antibacterial response.

  2018cites this paper
• Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway–PPAR Gamma, Energy Metabolism and Circadian Rhythms

  2018cites this paper
• Roco Proteins and the Parkinson’s Disease-Associated LRRK2

  2018cites this paper
• Identification of novel Wnt/PCP signaling regulators and their role in midbrain dopaminergic neuron development and Parkinson's disease

  2018cites this paper
• Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives

  2018cites this paper
• Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling

  2017cites this paper
• Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient‐derived induced pluripotent stem cells

  2017cites this paper
• A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway

  2017cites this paper
• LRRK2: An Emerging New Molecule in the Enteric Neuronal System That Quantitatively Regulates Neuronal Peptides and IgA in the Gut

  2017cites this paper
• Leucine-rich repeat kinase 2 exacerbates neuronal cytotoxicity through phosphorylation of histone deacetylase 3 and histone deacetylation

  2016cites this paper
• Cellular gene expression induced by parasite antigens and allergens in neonates from parasite-infected mothers.

  2016cites this paper
• LRRK 2 : an nence grise of Wnt-mediated neurogenesis ?

  2016cites this paper
• The role of the Wnt canonical signaling in neurodegenerative diseases.

  2016cites this paper
• Neural stem cell culture model for LRRK2 function determines regulation of dopaminergic and microtubule-associated genes

  2015cites this paper
• Identification of blood serum micro‐RNAs associated with idiopathic and LRRK2 Parkinson's disease

  2014cites this paper
• Gene and MicroRNA Transcriptome Analysis of Parkinson's Related LRRK2 Mouse Models

  2014cites this paper
• ERKed by LRRK2: a cell biological perspective on hereditary and sporadic Parkinson's disease.

  2014cites this paper
• Correlation between the biochemical pathways altered by mutated parkinson-related genes and chronic exposure to manganese.

  2014cites this paper
• LRRK2: an éminence grise of Wnt-mediated neurogenesis?

  2013cites this paper
• Down-regulation of LRRK2 in control and DAT transfected HEK cells increases manganese-induced oxidative stress and cell toxicity.

  2013cites this paper
• LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and Tropomyosin 4.

  2013cites this paper
• Leucine-rich repeat kinase 2 (Lrrk2): Functional characterization and interactome analysis of a protein kinase associated with Parkinson’s disease

  2012influential citation
• Phosphorylation of LRRK 2 : from kinase to substrate

  2012cites this paper
• LRRK2 functions as a Wnt signaling scaffold, bridging cytosolic proteins and membrane-localized LRP6

  2012cites this paper
• Phosphorylation of LRRK2: from kinase to substrate.

  2012cites this paper
• Comprehensive cytogenomic profile of the in vitro neuronal model SH-SY5Y

  2012cites this paper
• LRRK2 in Transcription and Translation Regulation: Relevance for Parkinson’s Disease

  2012influential citation
• The GTPase function of LRRK2.

  2012cites this paper
• NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease.

  2012cites this paper
• Microarray expression analysis in idiopathic and LRRK2-associated Parkinson's disease.

  2012cites this paper
• The importance of Wnt signalling for neurodegeneration in Parkinson's disease.

  2012cites this paper
• The GTPase function of LRRK 2

  2012cites this paper
• Differential expression of invasion promoting genes in childhood rhabdomyosarcoma.

  2011cites this paper
• On the Road to Leucine-Rich Repeat Kinase 2 Signalling: Evidence from Cellular and in vivo Studies

  2011cites this paper
• Tiny non-coding RNAs in Parkinson's disease: implications, expectations and hypes.

  2011cites this paper
• LRRK2 signaling pathways: the key to unlocking neurodegeneration?

  2011cites this paper
• Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation.

  2011cites this paper
• LRRK2 genetics and expression in the Parkinsonian brain

  2010cites this paper
• The proteomic approach to investigate Parkinson's desease: pathogenetic mechanisms and biomarkers discovery.

  2010cites this paper
• LRRK 2 and Parkinson Disease

  2010cites this paper
• LRRK2 and Parkinson disease.

  2010cites this paper
• The child is father to the man: Developmental roles for proteins of importance for neurodegenerative disease

  2010cites this paper
• ARHGEF7 (BETA-PIX) Acts as Guanine Nucleotide Exchange Factor for Leucine-Rich Repeat Kinase 2

  2010cites this paper
• Therapeutic targeting in the silent era: advances in non-viral siRNA delivery.

  2010cites this paper
• A QUICK Screen for Lrrk2 Interaction Partners – Leucine-rich Repeat Kinase 2 is Involved in Actin Cytoskeleton Dynamics*

  2010cites this paper
• Neurochemistry changes associated with mutations in familial Parkinson's disease.

  2010cites this paper
• Étude transcriptomique de cellules mononucléées sanguines de patients parkinsoniens porteurs de la mutation G2019S de LRRK2

  2010cites this paper
• LRRK2 in Parkinson’s disease: function in cells and neurodegeneration

  2009cites this paper
• Leucine‐rich repeat kinase 2 (LRRK2): A key player in the pathogenesis of Parkinson's disease

  2009cites this paper
• Emerging role of LRRK2 in human neural progenitor cell cycle progression, survival and differentiation

  2009cites this paper
• LRRK2 Modulates Vulnerability to Mitochondrial Dysfunction in Caenorhabditis elegans

  2009cites this paper
• Factors patogènics convergents en taupaties

  2009cites this paper
• New molecular avenues in Parkinson's disease therapy.

  2009cites this paper
• LRRK2 in Parkinson’s disease: biochemical functions

  2009cites this paper
• Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways

  2009cites this paper
• LRRK2 and neurodegeneration

  2009cites this paper
• Therapeutic Potential of Small Interfering RNA for Brain Diseases

  2009cites this paper
• Manganese-induced dopaminergic neurodegeneration: insights into mechanisms and genetics shared with Parkinson's disease.

  2009cites this paper
• Caenorhabditits elegans LRK-1 and PINK-1 Act Antagonistically in Stress Response and Neurite Outgrowth*

  2009cites this paper
• Update on the functional biology of Lrrk2.

  2008cites this paper
• ROCO Kinase Activity Is Controlled by Internal GTPase Function

  2008cites this paper
• Stem Cell Repor ts

  year unknowncites this paper